GlassScriptPhysician profile
Robert L Burgess
NPI 1326258807
$659.34
in general payments reported to CMS, 2019-2025
13 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2022: $58.38 · 2023: $57.34 · 2024: $262 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $266.66 | 2024-2025 | |
| Sirtex Medical INC | $125.77 | 2019 | |
| Teleflex LLC | $36.24 | 2023 | Arrow, Vsi |
| Stryker Corporation | $34.29 | 2022-2025 | Optablate |
| Cleerly, INC. | $32.06 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Siemens Medical Solutions USA, INC. | $30.45 | 2024-2025 | Somatom Go.Top, Somatom X.Cite |
| Medtronic, INC. | $28.51 | 2024 | Concertotm |
| Cordis US Corp. | $26.24 | 2022 | |
| Philips North America LLC | $21.10 | 2023 | |
| Terumo Medical Corporation | $17.10 | 2024 | Glidesheath Slender |
| Boston Scientific Corporation | $15.11 | 2024 | Embold Fibered |
| Smith+Nephew, INC. | $13.75 | 2024 | Grafix Pl, Stravix |
| Laborie Medical Technologies Corp. | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burgess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.